Karsten Munk Knudsen

Executive Vice President, Chief Financial Officer, Finance & Procurement · Novo Nordisk

Pharmaceuticals

Karsten Munk Knudsen is Novo Nordisk’s chief financial officer, with earlier leadership of US finance and IT and group corporate finance.

Last reviewed: Nov 15, 2026

Executive Summary

Karsten Munk Knudsen is Novo Nordisk’s chief financial officer, with earlier leadership of US finance and IT and group corporate finance.

Career Highlights

  • Entered Novo Nordisk through NNIT in 1999.
  • Led finance and IT at Novo Nordisk Inc. from 2010 to 2014.
  • Became CFO in February 2018 and remains incumbent in November 2026.

Professional Journey

Knudsen joined Novo Nordisk in 1999 as a business analyst at NNIT, then a subsidiary of the pharmaceutical group. He subsequently held finance positions across the company’s value chain before moving into senior leadership of its US organisation.

From 2010 to 2014, he was corporate vice president for Finance and IT at Novo Nordisk Inc. In 2014, he returned to a group position as senior vice president of Corporate Finance. He became executive vice president and chief financial officer in February 2018.

His portfolio expanded in 2019 to include legal and procurement responsibilities, followed by Global Solutions in 2022. These changes broadened his work beyond the group’s central finance function. His academic background is a master’s degree in finance from Aarhus University, awarded in 1998.

In November 2026, Novo Nordisk announced that he would leave at the end of December after agreeing a transition with the company. He remains the incumbent CFO during that period, while Luigi La Corte is the announced incoming successor. Knudsen signed the November 4 financial report as CFO alongside president and CEO Mike Doustdar.

Education

  • Aarhus University — M.Sc., Finance.